These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 28961413)

  • 1. Making Sense of Multifunctional Proteins: Human Immunodeficiency Virus Type 1 Accessory and Regulatory Proteins and Connections to Transcription.
    Faust TB; Binning JM; Gross JD; Frankel AD
    Annu Rev Virol; 2017 Sep; 4(1):241-260. PubMed ID: 28961413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 accessory proteins--ensuring viral survival in a hostile environment.
    Malim MH; Emerman M
    Cell Host Microbe; 2008 Jun; 3(6):388-98. PubMed ID: 18541215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual regulation of L-selectin (CD62L) by HIV-1: Enhanced expression by Vpr in contrast with cell-surface down-modulation by Nef and Vpu.
    Giuliani E; Vassena L; Galardi S; Michienzi A; Desimio MG; Doria M
    Virology; 2018 Oct; 523():121-128. PubMed ID: 30119013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of viral regulatory and accessory proteins in HIV-1 replication.
    Seelamgari A; Maddukuri A; Berro R; de la Fuente C; Kehn K; Deng L; Dadgar S; Bottazzi ME; Ghedin E; Pumfery A; Kashanchi F
    Front Biosci; 2004 Sep; 9():2388-413. PubMed ID: 15353294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 Vpu accessory protein induces caspase-mediated cleavage of IRF3 transcription factor.
    Park SY; Waheed AA; Zhang ZR; Freed EO; Bonifacino JS
    J Biol Chem; 2014 Dec; 289(51):35102-10. PubMed ID: 25352594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multilayered and versatile inhibition of cellular antiviral factors by HIV and SIV accessory proteins.
    Sauter D; Kirchhoff F
    Cytokine Growth Factor Rev; 2018 Apr; 40():3-12. PubMed ID: 29526437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral diversity and diversification of major non-structural genes vif, vpr, vpu, tat exon 1 and rev exon 1 during primary HIV-1 subtype C infection.
    Rossenkhan R; Novitsky V; Sebunya TK; Musonda R; Gashe BA; Essex M
    PLoS One; 2012; 7(5):e35491. PubMed ID: 22590503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune evasion activities of accessory proteins Vpu, Nef and Vif are conserved in acute and chronic HIV-1 infection.
    Mlcochova P; Apolonia L; Kluge SF; Sridharan A; Kirchhoff F; Malim MH; Sauter D; Gupta RK
    Virology; 2015 Aug; 482():72-8. PubMed ID: 25827531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1.
    Brumme ZL; Brumme CJ; Heckerman D; Korber BT; Daniels M; Carlson J; Kadie C; Bhattacharya T; Chui C; Szinger J; Mo T; Hogg RS; Montaner JS; Frahm N; Brander C; Walker BD; Harrigan PR
    PLoS Pathog; 2007 Jul; 3(7):e94. PubMed ID: 17616974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HIV-1 Vpu protein: a multifunctional enhancer of viral particle release.
    Bour S; Strebel K
    Microbes Infect; 2003 Sep; 5(11):1029-39. PubMed ID: 12941395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of HIV-1 gene expression.
    Cullen BR
    FASEB J; 1991 Jul; 5(10):2361-8. PubMed ID: 1712325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 accessory proteins: Vpu and Vif.
    Andrew A; Strebel K
    Methods Mol Biol; 2014; 1087():135-58. PubMed ID: 24158820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global HIV-1 molecular epidemiology with special reference to genetic analysis of HIV-1 subtypes circulating in North India: functional and pathogenic implications of genetic variation.
    Neogi U; Sood V; Banerjee S; Ghosh N; Verma S; Samrat S; Sharma Y; Saxena A; Husain S; Ramachandran VG; Das S; Sreedhar KV; Goel N; Wanchu A; Banerjea AC
    Indian J Exp Biol; 2009 Jun; 47(6):424-31. PubMed ID: 19634706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct Requirements for HIV-1 Accessory Proteins during Cell Coculture and Cell-Free Infection.
    Zotova A; Atemasova A; Pichugin A; Filatov A; Mazurov D
    Viruses; 2019 Apr; 11(5):. PubMed ID: 31027334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice.
    Aldrovandi GM; Zack JA
    J Virol; 1996 Mar; 70(3):1505-11. PubMed ID: 8627668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of apoptosis and viral latency - an axis to be well understood for successful cure of human immunodeficiency virus.
    Timilsina U; Gaur R
    J Gen Virol; 2016 Apr; 97(4):813-824. PubMed ID: 26764023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for inhibiting function of HIV-1 accessory proteins: a necessary route to AIDS therapy?
    Richter SN; Frasson I; Palù G
    Curr Med Chem; 2009; 16(3):267-86. PubMed ID: 19149577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmitted/Founder HIV-1 Subtype C Viruses Show Distinctive Signature Patterns in Vif, Vpr, and Vpu That Are Under Subsequent Immune Pressure During Early Infection.
    Rossenkhan R; MacLeod IJ; Brumme ZL; Magaret CA; Sebunya TK; Musonda R; Gashe BA; Edlefsen PT; Novitsky V; Essex M
    AIDS Res Hum Retroviruses; 2016; 32(10-11):1031-1045. PubMed ID: 27349335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remodeling of the Host Cell Plasma Membrane by HIV-1 Nef and Vpu: A Strategy to Ensure Viral Fitness and Persistence.
    Sugden SM; Bego MG; Pham TN; Cohen ÉA
    Viruses; 2016 Mar; 8(3):67. PubMed ID: 26950141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Functional roles of HIV-1 accessory genes for its pathogenicity].
    Adachi A; Kamada K; Hatcho K; Yamashita T; Uchiyama T; Nomaguchi M
    Tanpakushitsu Kakusan Koso; 2007 Aug; 52(10 Suppl):1261-7. PubMed ID: 17824250
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.